256 related articles for article (PubMed ID: 32945479)
1. Long non coding RNA OIP5‑AS1 promotes metastasis of breast cancer via miR‑340‑5p/ZEB2 axis.
Meng L; Yue X; Zhou D; Li H
Oncol Rep; 2020 Oct; 44(4):1662-1670. PubMed ID: 32945479
[TBL] [Abstract][Full Text] [Related]
2. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
3. Knockdown of lncRNA ZEB2NAT suppresses epithelial mesenchymal transition, metastasis and proliferation in breast cancer cells.
Eroğlu Güneş C; Güçlü E; Vural H; Kurar E
Gene; 2021 Dec; 805():145904. PubMed ID: 34418470
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA AFAP1-AS1 accelerates lung cancer cells migration and invasion by interacting with SNIP1 to upregulate c-Myc.
Zhong Y; Yang L; Xiong F; He Y; Tang Y; Shi L; Fan S; Li Z; Zhang S; Gong Z; Guo C; Liao Q; Zhou Y; Zhou M; Xiang B; Li X; Li Y; Zeng Z; Li G; Xiong W
Signal Transduct Target Ther; 2021 Jun; 6(1):240. PubMed ID: 34168109
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA ZEB2-AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple-negative breast cancer by epigenetically activating ZEB2.
Zhang G; Li H; Sun R; Li P; Yang Z; Liu Y; Wang Z; Yang Y; Yin C
J Cell Mol Med; 2019 May; 23(5):3271-3279. PubMed ID: 30825262
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
Xu C; Cui H; Li H; Wu Y; An H; Guo C
J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
[TBL] [Abstract][Full Text] [Related]
7. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway.
Xue M; Pang H; Li X; Li H; Pan J; Chen W
Cancer Sci; 2016 Jan; 107(1):18-27. PubMed ID: 26544536
[TBL] [Abstract][Full Text] [Related]
9. LncRNA UCA1 sponges miR-204-5p to promote migration, invasion and epithelial-mesenchymal transition of glioma cells via upregulation of ZEB1.
Liang C; Yang Y; Guan J; Lv T; Qu S; Fu Q; Zhao H
Pathol Res Pract; 2018 Sep; 214(9):1474-1481. PubMed ID: 30107990
[TBL] [Abstract][Full Text] [Related]
10. LncRNA UCA1 promotes tumor metastasis by inducing miR-203/ZEB2 axis in gastric cancer.
Gong P; Qiao F; Wu H; Cui H; Li Y; Zheng Y; Zhou M; Fan H
Cell Death Dis; 2018 Nov; 9(12):1158. PubMed ID: 30464170
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inhibited miR-338-3p suppresses breast cancer progression by directly targeting ZEB2.
He J; Wang J; Li S; Li T; Chen K; Zhang S
Cancer Sci; 2020 Oct; 111(10):3550-3563. PubMed ID: 32726486
[TBL] [Abstract][Full Text] [Related]
12. miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer.
Ji H; Sang M; Liu F; Ai N; Geng C
Pathol Res Pract; 2019 Apr; 215(4):697-704. PubMed ID: 30611621
[TBL] [Abstract][Full Text] [Related]
13. Lnc NR2F1-AS1 Promotes Breast Cancer Metastasis by Targeting the MiR-25-3p/ZEB2 Axis.
Zhai D; Zhou Y; Kuang X; Shao F; Zhen T; Lin Y; Wang Q; Shao N
Int J Med Sci; 2023; 20(9):1152-1162. PubMed ID: 37575267
[No Abstract] [Full Text] [Related]
14. Long non-coding RNA XIST promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer.
Li C; Wan L; Liu Z; Xu G; Wang S; Su Z; Zhang Y; Zhang C; Liu X; Lei Z; Zhang HT
Cancer Lett; 2018 Apr; 418():185-195. PubMed ID: 29339211
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA
Fan MJ; Zou YH; He PJ; Zhang S; Sun XM; Li CZ
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31092700
[TBL] [Abstract][Full Text] [Related]
16. LncRNA SPRY4‑IT1 promotes progression of osteosarcoma by regulating ZEB1 and ZEB2 expression through sponging of miR‑101 activity.
Yao H; Hou G; Wang QY; Xu WB; Zhao HQ; Xu YC
Int J Oncol; 2020 Jan; 56(1):85-100. PubMed ID: 31746422
[TBL] [Abstract][Full Text] [Related]
17. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.
Li J; Hao Y; Mao W; Xue X; Xu P; Liu L; Yuan J; Zhang D; Li N; Chen H; Zhao L; Sun Z; Luo J; Chen R; Zhao RC
J Hematol Oncol; 2019 Feb; 12(1):19. PubMed ID: 30795783
[TBL] [Abstract][Full Text] [Related]
18. lncRNA PCNAP1 predicts poor prognosis in breast cancer and promotes cancer metastasis via miR‑340‑5p‑dependent upregulation of SOX4.
Yu Y; He Y; Shao Y; Chen Q; Liu H
Oncol Rep; 2020 Oct; 44(4):1511-1523. PubMed ID: 32945462
[TBL] [Abstract][Full Text] [Related]
19. LncRNA XIST promotes the epithelial to mesenchymal transition of retinoblastoma via sponging miR-101.
Cheng Y; Chang Q; Zheng B; Xu J; Li H; Wang R
Eur J Pharmacol; 2019 Jan; 843():210-216. PubMed ID: 30472203
[TBL] [Abstract][Full Text] [Related]
20. Long non‑coding RNA OIP5‑AS1 facilitates the progression of ovarian cancer via the miR‑128‑3p/CCNG1 axis.
Liu Y; Fu X; Wang X; Liu Y; Song X
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
